表紙
市場調査レポート

米国:生検市場 & 件数の分析 2020年

United States - Biopsy Testing Market & Volume Analysis to 2020

発行 Renub Research 商品コード 349637
出版日 ページ情報 英文 53 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
米国:生検市場 & 件数の分析 2020年 United States - Biopsy Testing Market & Volume Analysis to 2020
出版日: 2016年01月12日 ページ情報: 英文 53 Pages
概要

米国の生検市場は2014年に150億米ドルを上回り、将来はさらに明るい見通しとなっています。米国の生検市場において、2014年は乳癌が最も多いセグメントとなりました。甲状腺癌は最下位に位置していますが、甲状腺癌は米国で最も急増している癌の種類です。しかし件数から分析すると、前立腺癌が最も大きいセグメントとなっています。米国における癌の有病率・高齢者人口の増加および低侵襲処置の需要の高まりは、予測期間中の市場成長を促進すると予測されています。

当レポートでは、米国の生検市場について包括的に調査し、癌の5大セグメントにおける市場分析と件数の予測、生検市場の促進因子と課題の分析などについて、まとめています。

第1章 エグゼクティブサマリー

第2章 米国の生検市場:件数・予測

  • 市場 & 予測
  • 件数 & 予測

第3章 米国の生検市場 & 件数シェア分析

  • 市場シェア & 予測
  • 件数シェア & 予測

第4章 米国の生検市場 & 件数予測:検査セグメントの分析

  • 前立腺癌
  • 乳癌
  • 肺癌
  • 肝臓癌
  • 甲状腺癌

第5章 米国の生検市場:成長促進因子

  • 特定の癌にとっては不十分な検査
  • 低侵襲生検技術の需要
  • 生検技術の進歩
    • 前立腺癌
    • 乳癌
    • 肺癌
    • 肝臓癌
    • 甲状腺癌

第6章 米国の生検市場:課題

  • 胸部生検医療費償還のバンドリング
  • 生検の限界

図表

目次

United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.

Renub Research report titled "United States - Biopsy Testing Market & Volume Analysis to 2020 " provides a comprehensive assessment of the fast-evolving, high-growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.

The United States Biopsy Market has been analyzed from two view points

  • United States Biopy Test Market & Forecast (2008 - 2020)
  • United States Biopy Test Volume & Forecast (2008 - 2020)

The Top 5 Cancer Segments covered are:

  • 1. Breast Cancer
  • 2. Prostate Cancer
  • 3. Liver Cancer
  • 4. Lung Cancer
  • 5. Thyroid Cancer

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. United States Biopsy Test Market, Volume & Forecast (2008 - 2020)

  • 2.1 United States Biopsy Test Market & Forecast
  • 2.2 United States Biopsy Test Volume & Forecast

3. United States Biopsy Test Market & Volume Share Analysis (2008 - 2020)

  • 3.1 United States Biopsy Test Market Share & Forecast
  • 3.2 United States Biopsy Test Volume Share & Forecast

4. United States Biopsy Market & Volume Forecast - Test Segment Analysis (2008 - 2020)

  • 4.1 United States - Prostate Cancer Biopsy Test Market & Volume Forecast
    • 4.1.1 United States - Prostate Cancer Biopsy Test Market & Forecast
    • 4.1.2 United States - Prostate Cancer Biopsy Test Volume & Forecast
  • 4.2 United States - Breast Cancer Biopsy Test Market & Volume Forecast
    • 4.2.1 United States - Breast Cancer Biopsy Test Market & Forecast
    • 4.2.2 United States - Breast Cancer Biopsy Test Volume & Forecast
  • 4.3 United States - Lung Cancer Biopsy Test Market & Volume Forecast
    • 4.3.1 United States - Lung Cancer Biopsy Test Market & Forecast
    • 4.3.2 United States - Lung Cancer Biopsy Test Volume & Forecast
  • 4.4 United States - Liver Cancer Biopsy Test Market & Volume Forecast
    • 4.4.1 United States - Liver Cancer Biopsy Test Market & Forecast
    • 4.4.2 United States - Liver Cancer Biopsy Test Volume & Forecast
  • 4.5 United States - Thyroid Cancer Biopsy Test Market & Volume Forecast
    • 4.5.1 United States - Thyroid Cancer Biopsy Test Market & Forecast
    • 4.5.2 United States - Thyroid Cancer Biopsy Test Volume & Forecast

5. United States Biopsy Test Market - Growth Drivers

  • 5.1 Inadequate Screening Tests for Particular Cancers
  • 5.2 Demand for Minimally-Invasive Biopsy Techniques
  • 5.3 Advancement in Biopsy Techniques
    • 5.3.1 Advances in Prostate Biopsy Techniques
    • 5.3.2 Advances in Breast Biopsy Techniques
    • 5.3.3 Advances in Lung Biopsy Techniques
    • 5.3.4 Advances in Liver Biopsy Techniques
    • 5.3.5 Advances in Thyroid Biopsy Techniques

6. United States Biopsy Test Market - Challenges

  • 6.1 Breast Biopsy Reimbursement Bundling
  • 6.2 Biopsy Limitations

List of Figures:

  • Figure 2-1: United States - Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 2-2: United States - Forecast for Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 2-3: United States - Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 2-4: United States - Forecast for Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 3-1: United States - Biopsy Test Market Share (Percent), 2008 - 2014
  • Figure 3-2: United States - Forecast for Biopsy Test Market Share (Percent), 2015 - 2020
  • Figure 3-3: United States - Biopsy Test Volume Share (Percent), 2008 - 2014
  • Figure 3-4: United States - Forecast for Biopsy Test Volume Share (Percent), 2015 - 2020
  • Figure 4-1: United States - Prostate Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-2: United States - Forecast for Prostate Cancer Biopsy Test Market (Million US$), 2015 -2020
  • Figure 4-3: United States - Prostate Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-4: United States - Forecast for Prostate Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-5: United States - Breast Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-6: United States - Forecast for Breast Cancer Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 4-7: United States - Breast Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-8: United States - Forecast for Breast Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-9: United States - Lung Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-10: United States - Forecast for Lung Cancer Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 4-11: United States - Lung Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-12: United States - Forecast for Lung Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-13: United States - Liver Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-14: United States - Forecast for Liver Cancer Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 4-15: United States - Liver Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-16: United States - Forecast for Liver Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-17: United States - Thyroid Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-18: United States - Forecast for Thyroid Cancer Biopsy Test Market (Million US$), 2015 -2020
  • Figure 4-19: United States - Thyroid Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-20: United States - Forecast for Thyroid Cancer Biopsy Test Volume (Thousand), 2015 -2020

List of Tables:

  • Table 6-1: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015
Back to Top